Stock 600285 HENAN LINGRUI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Henan Lingrui Pharmaceutical Co., Ltd.

Equities

600285

CNE000001501

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-06 pm EDT 		5-day change 1st Jan Change
26.75 CNY +2.14% Intraday chart for Henan Lingrui Pharmaceutical Co., Ltd. +5.11% +56.34%
Apr. 25 Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,621 4,809 8,920 7,358 9,649 14,149 - -
Enterprise Value (EV) 1 5,621 4,809 8,920 7,358 9,649 14,149 14,149 14,149
P/E ratio 19.3 x 14.8 x 24.8 x 15.9 x 17.1 x 22.1 x 19.5 x 16 x
Yield - - - 4.6% 4.68% 3.29% 3.85% -
Capitalization / Revenue 2.61 x - 3.31 x 2.45 x 2.91 x 3.77 x 3.23 x 2.95 x
EV / Revenue 2.61 x - 3.31 x 2.45 x 2.91 x 3.77 x 3.23 x 2.95 x
EV / EBITDA - - 19.5 x 12.4 x 13.1 x 19.8 x 17.3 x -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - - 3.94 x 2.9 x 3.48 x 5.03 x 4.68 x 4.23 x
Nbr of stocks (in thousands) 567,809 567,809 564,553 564,253 563,938 563,934 - -
Reference price 2 9.900 8.470 15.80 13.04 17.11 26.75 26.75 26.75
Announcement Date 4/28/20 4/28/21 4/25/22 4/25/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,157 - 2,694 3,002 3,311 3,752 4,381 4,791
EBITDA 1 - - 457.7 594.3 737 716 820 -
EBIT 1 - - 435 517.1 656.3 791 890 1,094
Operating Margin - - 16.15% 17.23% 19.82% 21.08% 20.31% 22.83%
Earnings before Tax (EBT) 1 - - 413.4 517 653 786 886.5 1,090
Net income 1 - 325.5 361.5 465.3 568.1 684 779.5 948
Net margin - - 13.42% 15.5% 17.16% 18.23% 17.79% 19.79%
EPS 2 0.5120 0.5730 0.6380 0.8190 1.003 1.210 1.375 1.670
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - 0.6000 0.8000 0.8800 1.030 -
Announcement Date 4/28/20 4/28/21 4/25/22 4/25/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - - 15.9% 19.3% 21.3% 22.7% 24% 26.5%
ROA (Net income/ Total Assets) - - - - - 12.6% 13.4% -
Assets 1 - - - - - 5,429 5,835 -
Book Value Per Share 2 - - 4.010 4.500 4.920 5.320 5.710 6.320
Cash Flow per Share 2 - - 1.490 1.470 1.430 1.200 1.330 1.500
Capex 1 - - - 14.8 11 80 81 -
Capex / Sales - - - 0.49% 0.33% 2.13% 1.85% -
Announcement Date 4/28/20 4/28/21 4/25/22 4/25/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Henan Lingrui Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
26.75
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+56.34% 2.09B
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+43.96% 6.34B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.56% 4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-6.52% 3.29B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+5.47% 3.2B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-0.76% 2.59B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-4.11% 1.76B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+2.93% 1.7B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.02% 1.62B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+49.62% 1.55B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 600285 Stock
  4. Financials Henan Lingrui Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW